Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 2 April 2027
- Last conf. stmt
- 19 March 2026
Spur Therapeutics Limited
- Incorporated
- 19 March 2015 (11 years)
- Previously known as
- Freeline Therapeutics Limited (until 27 September 2024)Newincco 1354 Limited (until 7 December 2015)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Henning Stennicke
- Accounts type
- Audit exemption subsidiary
- Region
- East of England
- Address
- Sycamore HouseGunnels Wood RoadStevenageSG1 2BP
Charges
- Total
- 9
- Outstanding
- 4
- Part satisfied
- 0
- Satisfied
- 5
Officers 3 active
Officer details are public data from the Companies House register.
Stennicke, Henning
Director · Appointed 17 August 2026
Danish
Born January 1968 (58)
Director · Appointed 15 July 2022
American
Born February 1968 (58)
Director · Appointed 31 May 2022
American
Born April 1970 (56)
Officer history (18 former)
17 August 2026
Appointed Stennicke, Henning as Director
31 July 2026
15 July 2022
15 July 2022
31 May 2022
31 May 2022
4 April 2022
4 April 2022
15 August 2021
30 April 2021
30 April 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
18 February 2021
4 June 2020
20 November 2019
11 September 2019
10 June 2019
20 November 2018
18 June 2018
Resigned Fagan, Richard, Dr as Director
26 September 2017
8 July 2016
13 August 2015
22 May 2015
22 May 2015
Appointed Fagan, Richard, Dr as Director
19 May 2015
19 May 2015
19 May 2015
19 May 2015
19 March 2015
19 March 2015
19 March 2015
19 March 2015
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 4 December 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 15295548
Former controllers (5)
4 December 2025
Ceased Freeline Holdings (UK) Limited — Owns 75–100% of shares
6 May 2021
Ceased Freeline Therapeutics Holdings PLC — Owns 75–100% of shares
27 June 2020
Ceased Syncona Limited — Owns 50–75% of shares
24 January 2017
Ceased Ucl Business PLC — Holds 25–50% of voting rights
20 December 2016
Ceased Syncona LLP — Owns 50–75% of shares
Group structure 5 companies
Ownership group derived from the Companies House PSC register
Spur Therapeutics Limited This company Owns 75–100% of shares
Swanbio Therapeutics Limited Owns 75–100% of shares
Filings 170
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 25 October 2026 | Other filing | |||
| 25 October 2026 | Other filing | |||
| 25 October 2026 | Accounts filing | |||
| 25 October 2026 | Audit exemption subsidiary accounts | 31 December 2025 | ||
| 20 August 2026 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →